2 unknown. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
| Phase 2 | 2 | Unknown 2 |
Follow Institute of Cell Therapy: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs Placenta-Derived MMSCs; Cryopreserved Placenta-Derived Multipotent Mesenchymal Stromal Cells, Antibiotics, Hormones - COVID-19 Pneumonia | Phase 1 / Phase 2 | Unknown | Institute of Cell Therapy | 30 | 2020-05-02 | 2020-07-08 |
| Efficacy of Bone-marrow-derived and Placenta-derived Multipotent Mesenchymal Stem / Stromal Cells for Osteoarthritis Placenta-derived MMSCs, Bone marrow-derived MMSCs, Hyalgan 20 mg in 2 ML Prefilled Syringe - Knee Osteoarthritis | Phase 1 / Phase 2 | Unknown | Institute of Cell Therapy | 45 | 2020-01-02 | 2020-07-07 |
Anti-Bacterial Agents (1) · Azithromycin (1) · Ceftriaxone (1) · Dexamethasone (1) · Hormones (1) · Hyaluronic Acid (1)
Ukraine (2)